Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Current Pain and Headache Reports
Erschienen in: Current Pain and Headache Reports 11/2023

01.09.2023 | Chronic Daily Headache (S-J Wang and S-P Chen, Section Editors)

Overlap and Differences in Migraine and Idiopathic Intracranial Hypertension

verfasst von: Sweta Sengupta, Jaskiran Vidwan

Erschienen in: Current Pain and Headache Reports | Ausgabe 11/2023

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

Migraine and idiopathic intracranial hypertension (IIH) are increasingly encountered but remain enigmatic. This review compares the similarities and differences of the diagnostic criteria, pathophysiology, and risk factors for chronic migraine and IIH.

Recent Findings

While migraine and IIH are distinct diseases, both conditions are frequently found concurrently and may share a link. Increased intracranial pressure (ICP) in those with or without pre-existing migraine may present with migraine-like headaches and contribute to migraine chronification. Increased intracranial pressure may be a coincidental occurrence in patients with migraine and normalization of pressure does not always translate to headache improvement. Limited information is available regarding the standard of treatment for patients with chronic migraine and IIH without papilledema.

Summary

There continues to be controversy over the normal range of cerebral spinal fluid (CSF) values. Recognizing the concurrence of both conditions advances our understanding of headache pathology and demonstrates a striking need for more research.
Literatur
1.
Munakata J, Hazard E, Serrano D, Klingman D, Rupnow MFT, Tierce J, et al. Economic burden of transformed migraine: results from the American Migraine Prevalence and Prevention (AMPP) Study. Headache: The Journal of Head and Face Pain. 2009;49(4):498–508.
2.
•• Mollan SP, Grech O, Sinclair AJ. Headache attributed to idiopathic intracranial hypertension and persistent post-idiopathic intracranial hypertension headache: a narrative review. Headache. 2021;61(6):808–16. A comprehensive review of persistent post-IIH headache.
3.
Blanch RJ, Vasseneix C, Liczkowski A, Yiangou A, Aojula A, Micieli JA, et al. Differing presenting features of idiopathic intracranial hypertension in the UK and US. Eye (Lond). 2019;33(6):1014–9.PubMedCrossRef
4.
Hoffmann J, Mollan SP, Paemeleire K, Lampl C, Jensen RH, Sinclair AJ. European Headache Federation guideline on idiopathic intracranial hypertension. J Headache Pain. 2018;19(1):93.PubMedPubMedCentralCrossRef
5.
Zur D, Naftaliev E, Kesler A. Evidence of multidomain mild cognitive impairment in idiopathic intracranial hypertension. J Neuroophthalmol. 2015;35(1):26–30.PubMedCrossRef
6.
Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018;38(1):1–211.
7.
Chalmer MA, Hansen TF, Lebedeva ER, Dodick DW, Lipton RB, Olesen J. Proposed new diagnostic criteria for chronic migraine. Cephalalgia. 2020;40(4):399–406.PubMedCrossRef
8.
Digre KB. Idiopathic intracranial hypertension headache. Curr Pain Headache Rep. 2002;6(3):217–25.PubMedCrossRef
9.
Funnell JP, Craven CL, D’Antona L, Thompson SD, Chari A, Thorne L, et al. Intracranial pressure in patients with papilloedema. Acta Neurol Scand. 2018;138(2):137–42.PubMedCrossRef
10.
Digre KB, Nakamoto BK, Warner JEA, Langeberg WJ, Baggaley SK, Katz BJ. A comparison of idiopathic intracranial hypertension with and without papilledema. Headache. 2009;49(2):185–93.
11.
Digre KB, Nakamoto BK, Warner JE, Langeberg WJ, Baggaley SK, Katz BJ. A comparison of idiopathic intracranial hypertension with and without papilledema. Headache. 2009;49(2):185–93.PubMedPubMedCentralCrossRef
12.
Wang SJ, Silberstein SD, Patterson S, Young WB. Idiopathic intracranial hypertension without papilledema: a case-control study in a headache center. Neurology. 1998;51(1):245–9.PubMedCrossRef
13.
•• Favoni V, Pierangeli G, Toni F, Cirillo L, La Morgia C, Abu-Rumeileh S, et al. Idiopathic intracranial hypertension without papilledema (IIHWOP) in chronic refractory headache. Front Neurol. 2018;9:503. (Highlights the prevalence of IIHWOP.)PubMedPubMedCentralCrossRef
14.
Corbett JJ, Mehta MP. Cerebrospinal fluid pressure in normal obese subjects and patients with pseudotumor cerebri. Neurology. 1983;33(10):1386-.
15.
Whiteley W, Al-Shahi R, Warlow CP, Zeidler M, Lueck CJ. CSF opening pressure: reference interval and the effect of body mass index. Neurology. 2006;67(9):1690–1.PubMedCrossRef
16.
• Mollan SP, Chong YJ, Grech O, Sinclair AJ, Wakerley BR. Current perspectives on idiopathic intracranial hypertension without papilloedema. Life. 2021;11(6):472. ()PubMedPubMedCentralCrossRef
17.
•• Friedman DI, Quiros PA, Subramanian PS, Mejico LJ, Gao S, McDermott M, et al. Headache in idiopathic intracranial hypertension: findings from the idiopathic intracranial hypertension treatment trial. Headache. 2017;57(8):1195–205. ()PubMedPubMedCentralCrossRef
18.
•• Adderley NJ, Subramanian A, Perrins M, Nirantharakumar K, Mollan SP, Sinclair AJ. Headache, opiate use, and prescribing trends in women with idiopathic intracranial hypertension: a population-based matched cohort study. Neurology. 2022;99(18):e1968–78. ()PubMedPubMedCentralCrossRef
19.
Friedman DI. Headaches in idiopathic intracranial hypertension. J Neuroophthalmol. 2019;39(1):82–93.PubMedCrossRef
20.
De Simone R, Marano E, Bilo L, Briganti F, Esposito M, Ripa P, et al. Idiopathic intracranial hypertension without headache. Cephalalgia. 2006;26(8):1020–1.PubMedCrossRef
21.
Sina F, Razmeh S, Habibzadeh N, Zavari A, Nabovvati M. Migraine headache in patients with idiopathic intracranial hypertension. Neurol Int. 2017;9(3):7280.PubMedPubMedCentralCrossRef
22.
D DA, Curone M, Ciasca P, Cammarata G, Melzi L, Bussone G, et al. Headache prevalence and clinical features in patients with idiopathic intracranial hypertension (IIH). Neurol Sci. 2013;34 Suppl 1:S147–9.
23.
Onder H, Ulusoy EK, Aslanyavrusu M, Akturk T, Arslan G, Akkurt I, et al. The prevalence of papilledema in patients with migraine: a crucial cooccurrence of migraine and idiopathic intracranial hypertension. Neurol Sci. 2020;41(9):2613–20.PubMedCrossRef
24.
De Simone R, Ranieri A, Montella S, Cappabianca P, Quarantelli M, Esposito F, et al. Intracranial pressure in unresponsive chronic migraine. J Neurol. 2014;261(7):1365–73.PubMedPubMedCentralCrossRef
25.
Vieira DS, Masruha MR, Gonçalves AL, Zukerman E, Senne Soares CA, Naffah-Mazzacoratti Mda G, et al. Idiopathic intracranial hypertension with and without papilloedema in a consecutive series of patients with chronic migraine. Cephalalgia. 2008;28(6):609–13.PubMedCrossRef
26.
27.
Goadsby PJ, Holland PR. An update: pathophysiology of migraine. Neurol Clin. 2019;37(4):651–71.PubMedCrossRef
28.
29.
Mollan SP, Ali F, Hassan-Smith G, Botfield H, Friedman DI, Sinclair AJ. Evolving evidence in adult idiopathic intracranial hypertension: pathophysiology and management. J Neurol Neurosurg Psychiatry. 2016;87(9):982–92.PubMedCrossRef
30.
Markey KA, Uldall M, Botfield H, Cato LD, Miah MA, Hassan-Smith G, et al. Idiopathic intracranial hypertension, hormones, and 11beta-hydroxysteroid dehydrogenases. J Pain Res. 2016;9:223–32.PubMedPubMedCentral
31.
• Wichmann TO, Damkier HH, Pedersen M. A brief overview of the cerebrospinal fluid system and its implications for brain and spinal cord diseases. Front Hum Neurosci. 2021;15: 737217. (An overview of CSF dynamics.)PubMedCrossRef
32.
Lenck S, Radovanovic I, Nicholson P, Hodaie M, Krings T, Mendes-Pereira V. Idiopathic intracranial hypertension: the veno glymphatic connections. Neurology. 2018;91(11):515–22.PubMedCrossRef
33.
Mondejar V, Patsalides A. The Role of arachnoid granulations and the glymphatic system in the pathophysiology of idiopathic intracranial hypertension. Curr Neurol Neurosci Rep. 2020;20(7):20.PubMedCrossRef
34.
Leishangthem L, SirDeshpande P, Dua D, Satti SR. Dural venous sinus stenting for idiopathic intracranial hypertension: an updated review. J Neuroradiol. 2019;46(2):148–54.PubMedCrossRef
35.
De Simone R, Ranieri A, Sansone M, Marano E, Russo CV, Sacca F, et al. Dural sinus collapsibility, idiopathic intracranial hypertension, and the pathogenesis of chronic migraine. Neurol Sci. 2019;40(Suppl 1):59–70.PubMedCrossRef
36.
Friedman DI, Rausch EA. Headache diagnoses in patients with treated idiopathic intracranial hypertension. Neurology. 2002;58(10):1551–3.PubMedCrossRef
37.
Togha M, Shirbache K, Rahmanzadeh R, Ghorbani Z, Yari Z, Refaeian F, et al. Prevalence of new-onset migraine in patients with idiopathic intracranial hypertension in comparison to the general population. Iran J Neurol. 2018;17(4):161–6.PubMedPubMedCentral
38.
Farhadi Z, Alidoost S, Behzadifar M, Mohammadibakhsh R, Khodadadi N, Sepehrian R, et al. The prevalence of migraine in Iran: a systematic review and meta-analysis. Iran Red Crescent Med J. 2016;18(10): e40061.PubMedPubMedCentralCrossRef
39.
Yri HM, Ronnback C, Wegener M, Hamann S, Jensen RH. The course of headache in idiopathic intracranial hypertension: a 12-month prospective follow-up study. Eur J Neurol. 2014;21(12):1458–64.PubMedCrossRef
40.
Smith SV, Friedman DI. The idiopathic intracranial hypertension treatment trial: a review of the outcomes. Headache. 2017;57(8):1303–10.PubMedCrossRef
41.
• Mollan SP, Wakerley BR, Alimajstorovic Z, Mitchell J, Ottridge R, Yiangou A, et al. Intracranial pressure directly predicts headache morbidity in idiopathic intracranial hypertension. J Headache Pain. 2021;22(1):118. ()PubMedPubMedCentralCrossRef
42.
van Alphen HA. Migraine, a result of increased CSF pressure: a new pathophysiological concept (preliminary report). Neurosurg Rev. 1986;9(1–2):121–4.PubMedCrossRef
43.
Mathew NT, Ravishankar K, Sanin LC. Coexistence of migraine and idiopathic intracranial hypertension without papilledema. Neurology. 1996;46(5):1226–30.PubMedCrossRef
44.
De Simone R, Ranieri A. The role of intracranial hypertension in the chronification of migraine. Neurol Sci. 2015;36(Suppl 1):23–8.PubMedCrossRef
45.
Kelly LP, Saindane AM, Bruce BB, Ridha MA, Riggeal BD, Newman NJ, et al. Does bilateral transverse cerebral venous sinus stenosis exist in patients without increased intracranial pressure? Clin Neurol Neurosurg. 2013;115(8):1215–9.PubMedCrossRef
46.
Wall M. The headache profile of idiopathic intracranial hypertension. Cephalalgia. 1990;10(6):331–5.PubMedCrossRef
47.
Wall M, George D. Idiopathic intracranial hypertension. A prospective study of 50 patients. Brain. 1991;114 ( Pt 1A):155–80.
48.
Giuseffi V, Wall M, Siegel PZ, Rojas PB. Symptoms and disease associations in idiopathic intracranial hypertension (pseudotumor cerebri): a case-control study. Neurology. 1991;41(2(Pt 1)):239–44.
49.
Vetvik KG, MacGregor EA. Sex differences in the epidemiology, clinical features, and pathophysiology of migraine. Lancet Neurol. 2017;16(1):76–87.PubMedCrossRef
50.
Bruce BB, Kedar S, Van Stavern GP, Monaghan D, Acierno MD, Braswell RA, et al. Idiopathic intracranial hypertension in men. Neurology. 2009;72(4):304–9.PubMedPubMedCentralCrossRef
51.
Sacco S, Ricci S, Degan D, Carolei A. Migraine in women: the role of hormones and their impact on vascular diseases. J Headache Pain. 2012;13(3):177–89.PubMedPubMedCentralCrossRef
52.
van Oosterhout WPJ, Schoonman GG, van Zwet EW, Dekkers OM, Terwindt GM, MaassenVanDenBrink A, et al. Female sex hormones in men with migraine. Neurology. 2018;91(4):e374–81.PubMed
53.
• Ailani J. Updates on management of headache in women and transgender women. Curr Opin Neurol. 2021;34(3):339–43. ()PubMedCrossRef
54.
• Thaller M, Wakerley BR, Abbott S, Tahrani AA, Mollan SP, Sinclair AJ. Managing idiopathic intracranial hypertension in pregnancy: practical advice. Pract Neurol. 2022;22(4):295–300. ()PubMedPubMedCentralCrossRef
55.
• Park DSJ, Park JSY, Sharma S, Sharma RA. Idiopathic intracranial hypertension in pregnancy. J Obstet Gynaecol Can. 2021;43(11):1292–5. ()PubMedCrossRef
56.
O’Reilly MW, Westgate CS, Hornby C, Botfield H, Taylor AE, Markey K, et al. A unique androgen excess signature in idiopathic intracranial hypertension is linked to cerebrospinal fluid dynamics. JCI Insight. 2019;4(6). Study evaluating androgen levels in women with IIH.
57.
• Mollan SP, Tahrani AA, Sinclair AJ. The potentially modifiable risk factor in idiopathic intracranial hypertension: body weight. Neurol Clin Pract. 2021;11(4):e504–7. ()PubMedPubMedCentralCrossRef
58.
59.
Hornby C, Mollan SP, Botfield H, O’Reilly MW, Sinclair AJ. Metabolic concepts in idiopathic intracranial hypertension and their potential for therapeutic intervention. J Neuroophthalmol. 2018;38(4):522–30.PubMedPubMedCentralCrossRef
60.
May A, Schulte LH. Chronic migraine: risk factors, mechanisms and treatment. Nat Rev Neurol. 2016;12(8):455–64.PubMedCrossRef
61.
Daniels AB, Liu GT, Volpe NJ, Galetta SL, Moster ML, Newman NJ, et al. Profiles of obesity, weight gain, and quality of life in idiopathic intracranial hypertension (pseudotumor cerebri). Am J Ophthalmol. 2007;143(4):635–41.PubMedCrossRef
62.
• Westgate CSJ, Israelsen IME, Jensen RH, Eftekhari S. Understanding the link between obesity and headache- with focus on migraine and idiopathic intracranial hypertension. J Headache Pain. 2021;22(1):123. ()PubMedPubMedCentralCrossRef
63.
64.
• Wang MTM, Bhatti MT, Danesh-Meyer HV. Idiopathic intracranial hypertension: Pathophysiology, diagnosis and management. J Clin Neurosci. 2022;95:172–9. ()PubMedCrossRef
65.
Walker CS, Li X, Whiting L, Glyn-Jones S, Zhang S, Hickey AJ, et al. Mice lacking the neuropeptide alpha-calcitonin gene-related peptide are protected against diet-induced obesity. Endocrinology. 2010;151(9):4257–69 (Animal-based study of anti-CGRP role in obesity).PubMedCrossRef
66.
• Etefagh HH, Shahmiri SS, Melali H, Sayadi M, Ansari H, Shahzamani A, et al. Bariatric surgery in migraine patients: CGRP level and weight loss. Obes Surg. 2022;32(11):3635–40. ()PubMedCrossRef
67.
• Jing F, Zou Q, Wang Y, Cai Z, Tang Y. Activation of microglial GLP-1R in the trigeminal nucleus caudalis suppresses central sensitization of chronic migraine after recurrent nitroglycerin stimulation. J Headache Pain. 2021;22(1):86. ()PubMedPubMedCentralCrossRef
68.
Chen J, Wall M. Epidemiology and risk factors for idiopathic intracranial hypertension. Int Ophthalmol Clin. 2014;54(1):1–11.PubMedCrossRef
69.
Thurtell MJ, Trotti LM, Bixler EO, Rye DB, Bliwise DL, Newman NJ, et al. Obstructive sleep apnea in idiopathic intracranial hypertension: comparison with matched population data. J Neurol. 2013;260(7):1748–51.PubMedPubMedCentralCrossRef
70.
Tiseo C, Vacca A, Felbush A, Filimonova T, Gai A, Glazyrina T, et al. Migraine and sleep disorders: a systematic review. J Headache Pain. 2020;21(1):126.PubMedPubMedCentralCrossRef
71.
Buse DC, Rains JC, Pavlovic JM, Fanning KM, Reed ML, Manack Adams A, et al. Sleep disorders among people with migraine: results from the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study. Headache. 2019;59(1):32–45.PubMedCrossRef
72.
• Yiangou A, Mitchell JL, Nicholls M, Chong YJ, Vijay V, Wakerley BR, et al. Obstructive sleep apnoea in women with idiopathic intracranial hypertension: a sub-study of the idiopathic intracranial hypertension weight randomised controlled trial (IIH: WT). J Neurol. 2022;269(4):1945–56. ()PubMedCrossRef
73.
Wall M, McDermott MP, Kieburtz KD, Corbett JJ, Feldon SE, Friedman DI, et al. Effect of acetazolamide on visual function in patients with idiopathic intracranial hypertension and mild visual loss: the idiopathic intracranial hypertension treatment trial. JAMA. 2014;311(16):1641–51.PubMedCrossRef
74.
Celebisoy N, Gökçay F, Sirin H, Akyürekli O. Treatment of idiopathic intracranial hypertension: topiramate vs acetazolamide, an open-label study. Acta Neurol Scand. 2007;116(5):322–7.PubMedCrossRef
75.
Scotton WJ, Botfield HF, Westgate CS, Mitchell JL, Yiangou A, Uldall MS, et al. Topiramate is more effective than acetazolamide at lowering intracranial pressure. Cephalalgia. 2019;39(2):209–18.PubMedCrossRef
76.
Mollan SP, Davies B, Silver NC, Shaw S, Mallucci CL, Wakerley BR, et al. Idiopathic intracranial hypertension: consensus guidelines on management. J Neurol Neurosurg Psychiatry. 2018;89(10):1088–100.PubMedCrossRef
77.
• Yiangou A, Mitchell JL, Fisher C, Edwards J, Vijay V, Alimajstorovic Z, et al. Erenumab for headaches in idiopathic intracranial hypertension: a prospective open-label evaluation. Headache. 2021;61(1):157–69. An open-label study of an anti-CGRP medication in IIH.
Metadaten
Titel
Overlap and Differences in Migraine and Idiopathic Intracranial Hypertension
verfasst von
Sweta Sengupta
Jaskiran Vidwan
Publikationsdatum
01.09.2023
Verlag
Springer US
Erschienen in
Current Pain and Headache Reports / Ausgabe 11/2023
Print ISSN: 1531-3433
Elektronische ISSN: 1534-3081
DOI
https://doi.org/10.1007/s11916-023-01166-7

Weitere Artikel der Ausgabe 11/2023

Current Pain and Headache Reports 11/2023 Zur Ausgabe

Regenerative Pain Medicine/Interventional Pain Medicine (E Cornett Bradley, Section Editor)

Analgesic Techniques for Rib Fractures—A Comprehensive Review Article

Episodic Migraine (S Parikh, Section Editor)

Neurovascular Compression-Induced Intracranial Allodynia May Be the True Nature of Migraine Headache: an Interpretative Review

Anesthetic Techniques in Pain Management (D Wang, Section Editor)

Current Neurostimulation Therapies for Chronic Pain Conditions

Acute Pain Medicine (R Urman, Section Editor)

Simulation-Based Education in Acute and Chronic Pain Training

Uncommon and/or Unusual Headaches and Syndromes (F Cohen, Section Editor)

Primary Cough Headache

Neuromodulation (A Abd-Elsayed, Section Editor)

Neuromodulation for the Sphenopalatine Ganglion—a Narrative Review

Neu im Fachgebiet AINS

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Klinik aktuell Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Häufigste Gründe für Brustschmerzen bei Kindern

06.05.2024 Pädiatrische Diagnostik Nachrichten

Akute Brustschmerzen sind ein Alarmsymptom par exellence, schließlich sind manche Auslöser lebensbedrohlich. Auch Kinder klagen oft über Schmerzen in der Brust. Ein Studienteam ist den Ursachen nachgegangen.

Aquatherapie bei Fibromyalgie wirksamer als Trockenübungen

03.05.2024 Fibromyalgiesyndrom Nachrichten

Bewegungs-, Dehnungs- und Entspannungsübungen im Wasser lindern die Beschwerden von Patientinnen mit Fibromyalgie besser als das Üben auf trockenem Land. Das geht aus einer spanisch-brasilianischen Vergleichsstudie hervor.

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

hier abonnieren
Bildnachweise